MedTrace Logo

A Non-interventional, Epidemiological, Registry-based Evaluation of Anaemia in Swedish Patients With Chronic Kidney Disease

NCT03643601 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14415

Last updated 2024-10-31

No results posted yet for this study

Summary

The primary purpose of this study is to describe renal anemia treatment patterns in non-dialysis dependent (ND) and dialysis dependent (DD) populations, with a particular focus on iron use in erythropoiesis stimulating agent (ESA) treated patients.

This study will also provide an epidemiological description of chronic kidney disease (CKD) associated anemia in relation to CKD stage, dialysis modality and underlying morbidity, as well as describe the relationship between inflammation and ESA treatment and describe the associated cardiovascular illness in ESA treated patients.

Conditions

  • Chronic Kidney Disease Associated Anemia

Interventions

OTHER

Non-Interventional

Epidemiological overview of CKD-associated anemia and treatment patterns, rather than to evaluate specific drugs

Sponsors & Collaborators

  • Astellas Pharma a/s

    lead INDUSTRY

Principal Investigators

  • Medical Advisor · Astellas Pharma a/s

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-24
Primary Completion
2018-12-04
Completion
2018-12-04

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03643601 on ClinicalTrials.gov